Adam D. Cutler serves as Executive at NAVIDEA BIOPHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Adam D. Cutler has executed 7 insider transactions totaling $14.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 5, 2025 involved selling 99,290 shares valued at $0.
Adam D. Cutler currently holds 99,290 shares of NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam D. Cutler has been a net seller of NAVB stock. They have purchased $0 and sold $14.9K worth of shares.
Adam D. Cutler's most recent insider trade was on Dec 5, 2025, when they sold 99,290 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.09 |
| Discretionary |
| Dec 14, 2023 | MURA | $0 | Award | 78,859 | $N/A | Discretionary |
| Jan 13, 2021 | NAVB | $0 | Award | 2,500 | $N/A | Discretionary |
| Feb 6, 2020 | NAVB | $0 | Award | 2,500 | $N/A | Discretionary |
| Feb 7, 2019 | NAVB | $0 | Award | 50,000 | $N/A | Discretionary |
| Jan 2, 2019 | NAVB | $0 | Award | 50,000 | $N/A | Discretionary |